See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. We might be a step closer to curing HIV, as researchers have developed ...
In the study published in the journal Emerging Microbes and Infections, the team demonstrated that the patented therapeutic candidate, an HIV-virus-like-particle (HLP), is 100 times more effective ...
More than 40 million people worldwide are living with HIV-1, which continues to be a major global health challenge due to its ability to persist silently within immune cells, evading complete ...
The key obstacle against the cure of human and simian immunodeficiency virus (HIV/SIV) infections is the reservoir of proviruses, which are robustly incorporated into the genomes of host CD4+ T cells.
Predictors of Survival Outcomes After Primary Treatment of Epithelial Ovarian Cancer in Lagos, Nigeria Nasopharyngeal carcinoma (NPC), a malignant neoplasm of the epithelium covering the nasopharynx, ...
A research team led by Professor Chu Hin (first right) and Professor Chen Zhiwei (first left) has discovered that inhibiting the BRD9 protein can effectively reactivate latent HIV-1. When used in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results